Biotech Ferronova boosts Series A round by $6m to advance cancer-detection technology for surgeons

Adelaide-based biotech Ferronova has raised $6 million to advance commercialisation of its technology to help surgeons detect and remove early-stage cancer cells while reducing the risk of undetected recurrence following surgery.

The capital raise was led by existing investors Uniseed/UniSuper,…


Click here to view the original article.